|
|
|
| With more than 65 years of sterile injectable manufacturing experience, Simtra BioPharma Solutions offers world-class GMP sterile fill and finish services, deep scientific and technical expertise, and a uniquely collaborative approach to support our customers’ strategic objectives. As two industry-leading CDMOs in the ADC field, MilliporeSigma and Simtra have forged a Strategic Alliance for Drug Substance and Drug Product ADC Manufacturing with the shared goal to delivering your drug development program to market more efficiently. |
|
|
|
| Three Key Actions To Minimize Dead Volumes | White Paper | Tecan | Minimizing liquid dead volume helps labs conserve costly reagents and scarce samples while boosting assay throughput. Learn how advanced liquid level detection technologies are driving efficiency. |
|
|
| Effects Of X-Ray Inspection On Pharmaceutical Products | White Paper | By Rob Rogers, Mettler-Toledo Product Inspection | Some manufacturers still have reservations about adopting X-ray inspection as a safe method of product inspection. Explore the potential effects of X-ray inspection on pharmaceutical products and more. |
|
|
|
|
|
By Andrew Walsh, Thomas Altmann, Joshua Anthes, et al. | This in-depth article describes risk in cleaning and provides a science- and risk-based framework for selecting analytical methods using ASTM International standards. | |
|
|
INDUSTRY INSIGHTS CONTINUED |
|
|
|
|
|
|
|
| How Intelligent Automation Transforms CQV Workflows | Guest Article/Blog | By Peter Liang, Solutions Engineer, ValGenesis | Read how intelligent automation is revolutionizing CQV in life sciences to eliminate manual bottlenecks, accelerate timelines, and enhance compliance in an era of increasing regulatory scrutiny. |
|
|
| NMR And Mass Spectrometry In Pharmaceutical Development | White Paper | By Joshua Hicks, Ph.D., Senior Scientist, Organic Spectroscopy, Catalent | Together, nuclear magnetic resonance (NMR) and MS analysis can definitively identify reference standards, active pharmaceutical ingredients (APIs), or final drug product composition. |
|
|
|
|
|
|
|
|
| Prioritizing Data Security Through Digital Transformation | Article | By John Atkinson, FUJIFILM Biotechnologies | Integrating advanced digitalization solutions and prioritizing data security can accelerate drug development while reducing costs and ensuring consistency across a global network. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| Join life sciences experts and global regulators this 9–10 December for the 2025 ISPE Pharma 4.0™ Conference in Barcelona, Spain, or virtually. This year's agenda spotlights how innovative enabling technologies including AI, machine learning, virtual and augmented reality, industrial internet of things, GxP cloud platforms, robotics, advanced modeling, and automation, are addressing key challenges like drug shortages and improving product availability. LEARN MORE |
|
|
| Connect With Pharmaceutical Online: |
|
|
|